| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 9 | 2020 | 331 | 3.000 |
Why?
|
| Acetylglucosamine | 6 | 2015 | 46 | 2.000 |
Why?
|
| Transcription Factors | 6 | 2020 | 753 | 1.390 |
Why?
|
| Neovascularization, Physiologic | 6 | 2020 | 164 | 1.280 |
Why?
|
| Mitochondria | 5 | 2020 | 643 | 1.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2012 | 219 | 1.100 |
Why?
|
| Endothelium, Vascular | 5 | 2020 | 371 | 1.080 |
Why?
|
| Nanofibers | 6 | 2018 | 21 | 1.030 |
Why?
|
| Wound Healing | 6 | 2019 | 260 | 0.930 |
Why?
|
| Endothelial Cells | 6 | 2019 | 384 | 0.770 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2020 | 9 | 0.740 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2020 | 25 | 0.730 |
Why?
|
| Bone Regeneration | 3 | 2018 | 20 | 0.710 |
Why?
|
| Autophagy | 2 | 2019 | 208 | 0.540 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2019 | 57 | 0.520 |
Why?
|
| Tensile Strength | 1 | 2015 | 90 | 0.500 |
Why?
|
| Cicatrix | 1 | 2015 | 60 | 0.490 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 4 | 2007 | 65 | 0.480 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 94 | 0.470 |
Why?
|
| Heat-Shock Proteins | 2 | 2012 | 69 | 0.470 |
Why?
|
| Skin | 2 | 2015 | 451 | 0.460 |
Why?
|
| Mitochondrial Turnover | 1 | 2013 | 3 | 0.460 |
Why?
|
| Karyopherins | 1 | 2013 | 11 | 0.460 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 66 | 0.440 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2004 | 411 | 0.440 |
Why?
|
| Collagen | 5 | 2019 | 636 | 0.430 |
Why?
|
| Tissue Scaffolds | 4 | 2019 | 111 | 0.410 |
Why?
|
| Fatty Acids | 1 | 2012 | 222 | 0.370 |
Why?
|
| Femur | 1 | 2011 | 113 | 0.370 |
Why?
|
| Organelle Biogenesis | 2 | 2020 | 34 | 0.360 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 183 | 0.350 |
Why?
|
| Mice | 14 | 2019 | 8474 | 0.340 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 267 | 0.330 |
Why?
|
| Animals | 19 | 2019 | 20881 | 0.320 |
Why?
|
| Skull | 2 | 2018 | 63 | 0.320 |
Why?
|
| Transfection | 4 | 2019 | 782 | 0.310 |
Why?
|
| Cell Movement | 3 | 2009 | 630 | 0.310 |
Why?
|
| Signal Transduction | 6 | 2015 | 2689 | 0.310 |
Why?
|
| Fractures, Bone | 2 | 2019 | 132 | 0.300 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1293 | 0.290 |
Why?
|
| Integrins | 1 | 2007 | 115 | 0.290 |
Why?
|
| Nanostructures | 1 | 2007 | 112 | 0.280 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2006 | 63 | 0.260 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2017 | 45 | 0.250 |
Why?
|
| Electroporation | 1 | 2004 | 11 | 0.250 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 258 | 0.240 |
Why?
|
| Lysophospholipids | 1 | 2006 | 209 | 0.240 |
Why?
|
| Phosphorylation | 5 | 2019 | 1200 | 0.240 |
Why?
|
| Interleukin-15 | 1 | 2004 | 66 | 0.240 |
Why?
|
| Cells, Cultured | 7 | 2019 | 2673 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 150 | 0.230 |
Why?
|
| Interleukin-2 | 1 | 2004 | 133 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 147 | 0.230 |
Why?
|
| Sphingosine | 1 | 2006 | 315 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 223 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 2791 | 0.200 |
Why?
|
| Cyclins | 2 | 1998 | 50 | 0.190 |
Why?
|
| Loneliness | 1 | 2021 | 20 | 0.190 |
Why?
|
| Multigene Family | 1 | 2000 | 93 | 0.180 |
Why?
|
| Osteogenesis | 2 | 2019 | 152 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2020 | 305 | 0.180 |
Why?
|
| Varicose Ulcer | 1 | 2021 | 42 | 0.180 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2012 | 51 | 0.180 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2019 | 4 | 0.180 |
Why?
|
| Autophagy-Related Proteins | 1 | 2019 | 17 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2019 | 34 | 0.170 |
Why?
|
| Endoderm | 1 | 2019 | 37 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1034 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2000 | 183 | 0.170 |
Why?
|
| Receptors, Serotonin | 1 | 2019 | 74 | 0.170 |
Why?
|
| Organogenesis | 1 | 2019 | 49 | 0.170 |
Why?
|
| Humans | 18 | 2021 | 68618 | 0.170 |
Why?
|
| Absorbable Implants | 3 | 2019 | 29 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 214 | 0.170 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1998 | 9 | 0.160 |
Why?
|
| Oncogenes | 1 | 2019 | 71 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2004 | 79 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2013 | 954 | 0.160 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 434 | 0.150 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 63 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 195 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2019 | 202 | 0.150 |
Why?
|
| Interferon-alpha | 1 | 2017 | 46 | 0.150 |
Why?
|
| Blood Vessels | 1 | 2017 | 102 | 0.140 |
Why?
|
| Protein Kinases | 2 | 2012 | 122 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2013 | 1692 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 700 | 0.140 |
Why?
|
| Nitric Oxide Synthase | 1 | 2017 | 163 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2018 | 212 | 0.140 |
Why?
|
| Neutrophils | 1 | 2017 | 204 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1174 | 0.140 |
Why?
|
| Inflammation | 2 | 2021 | 1030 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2006 | 1664 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2019 | 682 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2017 | 382 | 0.130 |
Why?
|
| Lymphocytes | 2 | 2007 | 228 | 0.120 |
Why?
|
| Heart | 1 | 2019 | 850 | 0.120 |
Why?
|
| Models, Biological | 3 | 2004 | 981 | 0.120 |
Why?
|
| Oncogene Protein v-akt | 2 | 2008 | 25 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 261 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 132 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 216 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.110 |
Why?
|
| Myoblasts, Cardiac | 1 | 2012 | 1 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.110 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2012 | 5 | 0.100 |
Why?
|
| Epoxy Compounds | 1 | 2012 | 20 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2004 | 43 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 102 | 0.100 |
Why?
|
| Cell Line | 3 | 2019 | 1752 | 0.100 |
Why?
|
| beta-Defensins | 1 | 2011 | 8 | 0.100 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 181 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2012 | 95 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2011 | 756 | 0.100 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 442 | 0.090 |
Why?
|
| Autoantigens | 2 | 2017 | 91 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 756 | 0.090 |
Why?
|
| Keratinocytes | 1 | 2011 | 68 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2011 | 132 | 0.090 |
Why?
|
| Rabbits | 1 | 2011 | 509 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1536 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2011 | 137 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2011 | 99 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 132 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2011 | 238 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 108 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 567 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 304 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 148 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2012 | 489 | 0.090 |
Why?
|
| Skin Ulcer | 1 | 2009 | 19 | 0.080 |
Why?
|
| Kinetics | 1 | 2011 | 1047 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 166 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 247 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1033 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 1026 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 1851 | 0.080 |
Why?
|
| Fumarates | 1 | 2008 | 28 | 0.080 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2008 | 74 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2009 | 249 | 0.070 |
Why?
|
| Male | 6 | 2019 | 37321 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 508 | 0.070 |
Why?
|
| Collagen Type I | 1 | 2008 | 175 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2007 | 97 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 314 | 0.070 |
Why?
|
| Cytokines | 1 | 2011 | 866 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 250 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 189 | 0.070 |
Why?
|
| Spleen | 1 | 2007 | 301 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2007 | 791 | 0.070 |
Why?
|
| RNA Stability | 1 | 2006 | 55 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 562 | 0.060 |
Why?
|
| Homeostasis | 1 | 2007 | 291 | 0.060 |
Why?
|
| Phenotype | 2 | 2007 | 947 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2006 | 231 | 0.060 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2004 | 7 | 0.060 |
Why?
|
| B7-2 Antigen | 1 | 2004 | 23 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 31 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2004 | 51 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 22 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 100 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 42 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 308 | 0.060 |
Why?
|
| Androstadienes | 1 | 2004 | 41 | 0.060 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 24 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 134 | 0.060 |
Why?
|
| Scleroderma, Systemic | 1 | 2008 | 446 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2004 | 230 | 0.060 |
Why?
|
| Cell Size | 1 | 2003 | 76 | 0.060 |
Why?
|
| Drosophila | 1 | 2003 | 37 | 0.060 |
Why?
|
| Trachea | 1 | 2003 | 48 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 282 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 44 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2008 | 902 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 271 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 370 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 659 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 597 | 0.050 |
Why?
|
| Polyomavirus | 1 | 2000 | 4 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 39 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2000 | 14 | 0.050 |
Why?
|
| Ion Transport | 1 | 2000 | 26 | 0.050 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2000 | 49 | 0.050 |
Why?
|
| Female | 4 | 2019 | 38074 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 63 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2000 | 108 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2000 | 55 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2000 | 80 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2000 | 97 | 0.040 |
Why?
|
| Embryoid Bodies | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 322 | 0.040 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2019 | 5 | 0.040 |
Why?
|
| Phagosomes | 1 | 2019 | 19 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 852 | 0.040 |
Why?
|
| ras Proteins | 1 | 2000 | 102 | 0.040 |
Why?
|
| Fluorobenzenes | 1 | 2019 | 10 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 38 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 100 | 0.040 |
Why?
|
| Forecasting | 1 | 2000 | 277 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2000 | 237 | 0.040 |
Why?
|
| Carbazoles | 1 | 2019 | 46 | 0.040 |
Why?
|
| Everolimus | 1 | 2019 | 26 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 37 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2019 | 71 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2019 | 54 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 80 | 0.040 |
Why?
|
| Rifabutin | 1 | 1998 | 5 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 1998 | 7 | 0.040 |
Why?
|
| Piperidines | 1 | 2019 | 123 | 0.040 |
Why?
|
| Quinones | 1 | 1998 | 13 | 0.040 |
Why?
|
| Benzoquinones | 1 | 1998 | 13 | 0.040 |
Why?
|
| Cyclin D | 1 | 1998 | 12 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 50 | 0.040 |
Why?
|
| Mesoderm | 1 | 2019 | 231 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 142 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 284 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 326 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 349 | 0.040 |
Why?
|
| Benzamides | 1 | 2019 | 156 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2018 | 64 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 118 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2018 | 90 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 536 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 328 | 0.040 |
Why?
|
| Pyridines | 1 | 2019 | 261 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 45 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2018 | 132 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 230 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 1996 | 21 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1996 | 32 | 0.040 |
Why?
|
| Calcium | 1 | 2000 | 929 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1996 | 35 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 232 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2017 | 324 | 0.030 |
Why?
|
| Neomycin | 1 | 1996 | 56 | 0.030 |
Why?
|
| Kidney | 1 | 2019 | 945 | 0.030 |
Why?
|
| Insulin | 1 | 2017 | 619 | 0.030 |
Why?
|
| Base Sequence | 2 | 2007 | 1015 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3705 | 0.030 |
Why?
|
| Allantois | 1 | 2012 | 3 | 0.030 |
Why?
|
| Quality of Life | 1 | 2021 | 1515 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2017 | 447 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2012 | 146 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1174 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 1070 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 189 | 0.020 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2008 | 3 | 0.020 |
Why?
|
| 2,4-Dinitrophenol | 1 | 2008 | 6 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2008 | 33 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 17 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2008 | 47 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 71 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2008 | 86 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2008 | 396 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 51 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 38 | 0.020 |
Why?
|
| Actins | 1 | 2008 | 249 | 0.020 |
Why?
|
| Heterozygote | 1 | 2007 | 174 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 383 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 246 | 0.020 |
Why?
|
| Biopsy | 1 | 2008 | 540 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 142 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 384 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14862 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2004 | 8 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 28 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1447 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 302 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 81 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1553 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 369 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1996 | 9 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1996 | 37 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1996 | 75 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1996 | 77 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 91 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 1996 | 332 | 0.010 |
Why?
|